LBT Innovations’ Technology Aims to Speed Up Detection of Antimicrobial Resistance
Manage episode 307778346 series 3009792
It’s World Antimicrobial Awareness Week and we are shining a light on Australia’s expertise and innovations to fight antimicrobial resistance (AMR) and superbugs.
In this episode, we catch up with LBT Innovations, a groundbreaking South Australian company designing advanced medical technologies that automate culture plate reading and improve medical diagnostic workflows.
Their Chief Executive Officer, Brent Barnes, provides an update on the world-first APAS Independence, their automated plate reading technology now making headway into US and European markets, and a project funded by MTPConnect’s Biomedical Translation Bridge (BTB) program that is developing the use of artificial intelligence to help speed up the detection of antimicrobial resistance, improve antibiotic stewardship and ultimately help patients get the treatment they need.
Joining host Caroline Duell is Andrew Milligan from the Medical Device Partnering Program based in South Australia. MDPP is one of the Venture Partners for the BTB program and Andrew supports BTB awardees, like LBT Innovations with mentoring and project support.